Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals
Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Method...
Gespeichert in:
Veröffentlicht in: | Diabetes & metabolism 2015-04, Vol.41 (2), p.126-131 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 131 |
---|---|
container_issue | 2 |
container_start_page | 126 |
container_title | Diabetes & metabolism |
container_volume | 41 |
creator | Liatis, S Mylona, M Kalopita, S Papazafiropoulou, A Karamagkiolis, S Melidonis, A Xilomenos, A Ioannidis, I Kaltsas, G Lanaras, L Papas, S Basagiannis, C Kokkinos, A |
description | Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Methods Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients’ diabetes clinics of the same hospitals during the same time period. Results Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7 ± 10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7 ± 18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20–1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5–6.36]), use of insulin (OR: 2.35 [1.42–3.95]), lower estimated GFR (OR: 1.15 [1.07–1.23] at 10 mL/min) and number of comorbidities (OR: 1.74 [1.34–2.27]) were each independently associated with hypoglycaemia requiring medical assistance. Conclusion Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas. |
doi_str_mv | 10.1016/j.diabet.2014.10.006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1673078915</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1262363614001670</els_id><sourcerecordid>1673078915</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-f62b12b4bcea38db5909b7b3841e2350036580f6b442046a4cc5aa4b40a3bb4c3</originalsourceid><addsrcrecordid>eNqFkctuFDEQRS1ERELgDxDykk0PfrXbwwIpioAgRWKRsLZsT03ioV-x3RO1xMenWh1YsGFVpdKt17mEvONswxnXHw-bXXQeykYwrrC0YUy_IGfcNKbijWEvMRdaVFJLfUpe53xgjIutNK_IqaiVNkrpM_L7ah6Hu3YODrroaIKHKabY39EOdjG4lrqcYy6uD0BjT0dXIvQl08dY7ul6AORP9IKOacgjhBKPQLupLTGgLgHNUzrCvPQWSCW6NNN7VMbi2vyGnOwxwNvneE5-fv1ye3lVXf_49v3y4roKyjSl2mvhufDKB3DS7Hy9ZVvfeGkUByFrxqSuDdtrr5RgSjsVQu2c8oo56b0K8px8WOfikQ8T5GK7mAO0rethmLLlupGsMVteo1St0oD_5AR7O6bY4dWWM7twtwe7vm0X7ksVuWPb--cNk0dyf5v-gEbB51UA-OcxQrI5IMmAlBNSs7sh_m_DvwNCG_vFol8wQz4MU-qRoeU2C8vszeL9Yj1XaLtumHwCS56tcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1673078915</pqid></control><display><type>article</type><title>Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Liatis, S ; Mylona, M ; Kalopita, S ; Papazafiropoulou, A ; Karamagkiolis, S ; Melidonis, A ; Xilomenos, A ; Ioannidis, I ; Kaltsas, G ; Lanaras, L ; Papas, S ; Basagiannis, C ; Kokkinos, A</creator><creatorcontrib>Liatis, S ; Mylona, M ; Kalopita, S ; Papazafiropoulou, A ; Karamagkiolis, S ; Melidonis, A ; Xilomenos, A ; Ioannidis, I ; Kaltsas, G ; Lanaras, L ; Papas, S ; Basagiannis, C ; Kokkinos, A</creatorcontrib><description>Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Methods Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients’ diabetes clinics of the same hospitals during the same time period. Results Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7 ± 10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7 ± 18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20–1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5–6.36]), use of insulin (OR: 2.35 [1.42–3.95]), lower estimated GFR (OR: 1.15 [1.07–1.23] at 10 mL/min) and number of comorbidities (OR: 1.74 [1.34–2.27]) were each independently associated with hypoglycaemia requiring medical assistance. Conclusion Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas.</description><identifier>ISSN: 1262-3636</identifier><identifier>EISSN: 1878-1780</identifier><identifier>DOI: 10.1016/j.diabet.2014.10.006</identifier><identifier>PMID: 25468446</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Diabetes Mellitus, Type 1 - drug therapy ; Diabetes Mellitus, Type 2 - drug therapy ; Endocrinology & Metabolism ; Female ; Hospitalization ; Humans ; Hypoglycaemia ; Hypoglycemia - chemically induced ; Hypoglycemia - epidemiology ; Hypoglycemia - therapy ; Hypoglycemic Agents - adverse effects ; Hypoglycemic Agents - therapeutic use ; Insulin - adverse effects ; Insulin - therapeutic use ; Internal Medicine ; Male ; Middle Aged ; Prevalence ; Prospective Studies ; Sulfonylurea Compounds - adverse effects ; Sulfonylurea Compounds - therapeutic use ; Tertiary Care Centers ; Type 1 diabetes ; Type 2 diabetes ; Young Adult</subject><ispartof>Diabetes & metabolism, 2015-04, Vol.41 (2), p.126-131</ispartof><rights>Elsevier Masson SAS</rights><rights>2014 Elsevier Masson SAS</rights><rights>Copyright © 2014 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-f62b12b4bcea38db5909b7b3841e2350036580f6b442046a4cc5aa4b40a3bb4c3</citedby><cites>FETCH-LOGICAL-c487t-f62b12b4bcea38db5909b7b3841e2350036580f6b442046a4cc5aa4b40a3bb4c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1262363614001670$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25468446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liatis, S</creatorcontrib><creatorcontrib>Mylona, M</creatorcontrib><creatorcontrib>Kalopita, S</creatorcontrib><creatorcontrib>Papazafiropoulou, A</creatorcontrib><creatorcontrib>Karamagkiolis, S</creatorcontrib><creatorcontrib>Melidonis, A</creatorcontrib><creatorcontrib>Xilomenos, A</creatorcontrib><creatorcontrib>Ioannidis, I</creatorcontrib><creatorcontrib>Kaltsas, G</creatorcontrib><creatorcontrib>Lanaras, L</creatorcontrib><creatorcontrib>Papas, S</creatorcontrib><creatorcontrib>Basagiannis, C</creatorcontrib><creatorcontrib>Kokkinos, A</creatorcontrib><title>Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals</title><title>Diabetes & metabolism</title><addtitle>Diabetes Metab</addtitle><description>Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Methods Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients’ diabetes clinics of the same hospitals during the same time period. Results Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7 ± 10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7 ± 18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20–1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5–6.36]), use of insulin (OR: 2.35 [1.42–3.95]), lower estimated GFR (OR: 1.15 [1.07–1.23] at 10 mL/min) and number of comorbidities (OR: 1.74 [1.34–2.27]) were each independently associated with hypoglycaemia requiring medical assistance. Conclusion Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Endocrinology & Metabolism</subject><subject>Female</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Hypoglycaemia</subject><subject>Hypoglycemia - chemically induced</subject><subject>Hypoglycemia - epidemiology</subject><subject>Hypoglycemia - therapy</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin - adverse effects</subject><subject>Insulin - therapeutic use</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Sulfonylurea Compounds - adverse effects</subject><subject>Sulfonylurea Compounds - therapeutic use</subject><subject>Tertiary Care Centers</subject><subject>Type 1 diabetes</subject><subject>Type 2 diabetes</subject><subject>Young Adult</subject><issn>1262-3636</issn><issn>1878-1780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctuFDEQRS1ERELgDxDykk0PfrXbwwIpioAgRWKRsLZsT03ioV-x3RO1xMenWh1YsGFVpdKt17mEvONswxnXHw-bXXQeykYwrrC0YUy_IGfcNKbijWEvMRdaVFJLfUpe53xgjIutNK_IqaiVNkrpM_L7ah6Hu3YODrroaIKHKabY39EOdjG4lrqcYy6uD0BjT0dXIvQl08dY7ul6AORP9IKOacgjhBKPQLupLTGgLgHNUzrCvPQWSCW6NNN7VMbi2vyGnOwxwNvneE5-fv1ye3lVXf_49v3y4roKyjSl2mvhufDKB3DS7Hy9ZVvfeGkUByFrxqSuDdtrr5RgSjsVQu2c8oo56b0K8px8WOfikQ8T5GK7mAO0rethmLLlupGsMVteo1St0oD_5AR7O6bY4dWWM7twtwe7vm0X7ksVuWPb--cNk0dyf5v-gEbB51UA-OcxQrI5IMmAlBNSs7sh_m_DvwNCG_vFol8wQz4MU-qRoeU2C8vszeL9Yj1XaLtumHwCS56tcA</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Liatis, S</creator><creator>Mylona, M</creator><creator>Kalopita, S</creator><creator>Papazafiropoulou, A</creator><creator>Karamagkiolis, S</creator><creator>Melidonis, A</creator><creator>Xilomenos, A</creator><creator>Ioannidis, I</creator><creator>Kaltsas, G</creator><creator>Lanaras, L</creator><creator>Papas, S</creator><creator>Basagiannis, C</creator><creator>Kokkinos, A</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals</title><author>Liatis, S ; Mylona, M ; Kalopita, S ; Papazafiropoulou, A ; Karamagkiolis, S ; Melidonis, A ; Xilomenos, A ; Ioannidis, I ; Kaltsas, G ; Lanaras, L ; Papas, S ; Basagiannis, C ; Kokkinos, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-f62b12b4bcea38db5909b7b3841e2350036580f6b442046a4cc5aa4b40a3bb4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Endocrinology & Metabolism</topic><topic>Female</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Hypoglycaemia</topic><topic>Hypoglycemia - chemically induced</topic><topic>Hypoglycemia - epidemiology</topic><topic>Hypoglycemia - therapy</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin - adverse effects</topic><topic>Insulin - therapeutic use</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Sulfonylurea Compounds - adverse effects</topic><topic>Sulfonylurea Compounds - therapeutic use</topic><topic>Tertiary Care Centers</topic><topic>Type 1 diabetes</topic><topic>Type 2 diabetes</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liatis, S</creatorcontrib><creatorcontrib>Mylona, M</creatorcontrib><creatorcontrib>Kalopita, S</creatorcontrib><creatorcontrib>Papazafiropoulou, A</creatorcontrib><creatorcontrib>Karamagkiolis, S</creatorcontrib><creatorcontrib>Melidonis, A</creatorcontrib><creatorcontrib>Xilomenos, A</creatorcontrib><creatorcontrib>Ioannidis, I</creatorcontrib><creatorcontrib>Kaltsas, G</creatorcontrib><creatorcontrib>Lanaras, L</creatorcontrib><creatorcontrib>Papas, S</creatorcontrib><creatorcontrib>Basagiannis, C</creatorcontrib><creatorcontrib>Kokkinos, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes & metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liatis, S</au><au>Mylona, M</au><au>Kalopita, S</au><au>Papazafiropoulou, A</au><au>Karamagkiolis, S</au><au>Melidonis, A</au><au>Xilomenos, A</au><au>Ioannidis, I</au><au>Kaltsas, G</au><au>Lanaras, L</au><au>Papas, S</au><au>Basagiannis, C</au><au>Kokkinos, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals</atitle><jtitle>Diabetes & metabolism</jtitle><addtitle>Diabetes Metab</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>41</volume><issue>2</issue><spage>126</spage><epage>131</epage><pages>126-131</pages><issn>1262-3636</issn><eissn>1878-1780</eissn><abstract>Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Methods Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients’ diabetes clinics of the same hospitals during the same time period. Results Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7 ± 10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7 ± 18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20–1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5–6.36]), use of insulin (OR: 2.35 [1.42–3.95]), lower estimated GFR (OR: 1.15 [1.07–1.23] at 10 mL/min) and number of comorbidities (OR: 1.74 [1.34–2.27]) were each independently associated with hypoglycaemia requiring medical assistance. Conclusion Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>25468446</pmid><doi>10.1016/j.diabet.2014.10.006</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1262-3636 |
ispartof | Diabetes & metabolism, 2015-04, Vol.41 (2), p.126-131 |
issn | 1262-3636 1878-1780 |
language | eng |
recordid | cdi_proquest_miscellaneous_1673078915 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Aged Aged, 80 and over Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 2 - drug therapy Endocrinology & Metabolism Female Hospitalization Humans Hypoglycaemia Hypoglycemia - chemically induced Hypoglycemia - epidemiology Hypoglycemia - therapy Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Insulin - adverse effects Insulin - therapeutic use Internal Medicine Male Middle Aged Prevalence Prospective Studies Sulfonylurea Compounds - adverse effects Sulfonylurea Compounds - therapeutic use Tertiary Care Centers Type 1 diabetes Type 2 diabetes Young Adult |
title | Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T16%3A04%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypoglycaemia%20requiring%20medical%20assistance%20in%20patients%20with%20diabetes:%20A%20prospective%20multicentre%20survey%20in%20tertiary%20hospitals&rft.jtitle=Diabetes%20&%20metabolism&rft.au=Liatis,%20S&rft.date=2015-04-01&rft.volume=41&rft.issue=2&rft.spage=126&rft.epage=131&rft.pages=126-131&rft.issn=1262-3636&rft.eissn=1878-1780&rft_id=info:doi/10.1016/j.diabet.2014.10.006&rft_dat=%3Cproquest_cross%3E1673078915%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1673078915&rft_id=info:pmid/25468446&rft_els_id=S1262363614001670&rfr_iscdi=true |